mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
embelin |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.03 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.03 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.04 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.04 |